Login / Signup
Marwan Sheikh-Taha
Scopus Author ID
ORCID
Publication Activity (10 Years)
Years Active: 2017-2024
Publications (10 Years): 5
2025
2016
Top Topics
2025
2016
Peritoneal Dialysis
2025
2016
Primary Care
2025
2016
Drug Induced
2025
2016
Acute Heart Failure
Top Venues
American journal of cardiovascular drugs : drugs, devices, and other interventions
Clinical drug investigation
BMC cardiovascular disorders
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Marwan Sheikh-Taha
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure.
American journal of cardiovascular drugs : drugs, devices, and other interventions
24 (5) (2024)
Marwan Sheikh-Taha
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure.
American journal of cardiovascular drugs : drugs, devices, and other interventions
24 (5) (2024)
Marwan Sheikh-Taha
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure.
American journal of cardiovascular drugs : drugs, devices, and other interventions
(2024)
Marwan Sheikh-Taha
,
Holly L Clark
,
R Monroe Crawley
Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding.
Clinical drug investigation
(2023)
Marwan Sheikh-Taha
,
Hani Dimassi
Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.
BMC cardiovascular disorders
17 (1) (2017)